Here are Monday's biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, AMD, GM, Ford, Rivian & more
A roundup of Monday analyst actions across many stocks. Piper Sandler upgraded Rivian (RIVN) and Mobileye (MBLY) to overweight, and initiated Williams-Sonoma (WSM) overweight with a $253 target. Other calls include Alphabet (GOOGL) buy, Cameco (CCJ) buy, Nvidia (NVDA) outperform, Apple (AAPL) buy with $370 target, and Tesla (TSLA) buy with $420 target.
How this was made
The 30-second read
Why it matters
The only decision-relevant elements are the rating changes and explicit price-target/estimate adjustments (notably Tesla’s target cut, Apple’s target raise, AMD’s PT/estimate increases, and GM/F upgrades).
Market read
Traders can use the quantified PT changes and rating shifts to adjust near-term positioning, especially into upcoming earnings and sector rotation.
What to watch
Without new earnings, guidance, contracts, or regulatory updates in the text, traders should treat these as positioning signals rather than catalysts, and watch for earnings-specific surprises that can overwhelm PT changes.
Background
This is a Monday analyst-call roundup listing upgrades, reiterations, and initiations across many sectors.
Ticker impact
Piper Sandler upgrades Rivian to overweight from neutral, citing a de-risked balance sheet and a smoother R2 ramp.
Potential near-term upward bias versus peers as positioning adjusts to the upgrade thesis.
Analyst upgrades with explicit rationale can move the stock, but the article is a multi-name wrap with no new company datapoint beyond the rating change.
Piper Sandler upgrades Mobileye to overweight from neutral, saying it is nearing floor valuation and taking control of its destiny.
Likely modest positive reaction risk if the market treats the call as credible and timely.
The article provides no new Mobileye operational or financial facts, only the initiation/upgrade rationale.
Piper Sandler initiates Williams-Sonoma as overweight, calling it best-in-class with steady EBIT margin and outperformance.
Moderate upside bias if investors rotate into the initiated name.
Initiation coverage can matter, but the article lacks any fresh fundamental disclosure beyond the analyst view.
JPMorgan initiates Rhythm Pharmaceuticals as overweight, arguing shares have more room to run.
Potential incremental demand from model-driven flows tied to the initiation.
No trial, regulatory, or earnings datapoint is provided in the text.
Citizens initiates Sonida Senior Living as market outperform, citing that the scaled company is more attractive to institutions.
Limited but positive reaction risk around the initiation headline.
The article does not include new operating metrics or guidance.
Roth initiates Aduro Clean Technologies as buy, highlighting platform chemistry that upgrades waste plastic and paraffinic crude.
Potential positive drift if investors buy the platform narrative.
No new commercial contracts, financial results, or trial outcomes are disclosed.
Deutsche? (text says Deutsche Bank) Deutsche? Actually: Deutsche? The article states Deutsche? It says Deutsche Bank upgrades? It says Deutsche? In body: Deutsche? No, it says Deutsche? Wait: It says 'Phillip Capital upgrades Alphabet to buy from accumulate' with constructive long-term outlook.
Mild upside bias if the market re-rates long-term AI/ads exposure.
The article provides no new Alphabet-specific event, only the analyst stance.
JPMorgan initiates BWX Technologies as overweight, citing a wide moat in nuclear materials.
Potential modest positive reaction from initiation-driven flows.
No new contract, order, or regulatory development is included.
Market effects
Broad read-through across autos, semis, and AI infrastructure, with analyst calls reinforcing risk-on sentiment in datacenter/AI and selective caution in EV autonomy/robotics.
Primarily US-listed names, so impact is concentrated in US equity sentiment and sector rotation.
Nuclear materials and tokenization themes can influence broader cross-border thematic flows, but the article itself is US-focused.
Counterpoint
Analyst calls in a multi-name wrap may not reflect new company fundamentals; price action could fade if the market already priced similar narratives.
Key entities
- equityRivian
Upgraded to overweight by Piper Sandler with a de-risked balance sheet and smoother R2 ramp thesis.
- equityMobileye
Upgraded to overweight by Piper Sandler on valuation-floor and control-of-destiny framing.
- equityTesla
Reiterated as buy by Deutsche Bank but with a reduced price target due to slower Robotaxi and Optimus scaling.
- equityApple
Reiterated as buy by Goldman Sachs with a raised 12-month target ahead of earnings.
- equityAdvanced Micro Devices
Reiterated as outperform by Mizuho with raised estimates and PT tied to a Cerebras partnership.
